Use of Continuous Passive Motion in the Post-Operative Treatment of Intra-articular Knee Fractures
NCT ID: NCT00591929
Last Updated: 2013-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2006-12-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
NCT04389749
Outcome After Plate Osteosynthesis of Proximal Humerus Fractures Using Continous Passive Motioning Therapy
NCT05952622
Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair
NCT03407612
Continuous Pressure Monitoring In Lower Leg Fractures
NCT00358514
Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws
NCT06409559
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No Continuous passive motion following ORIF of fractures around the knee
No interventions assigned to this group
2
Continuous Passive Motion following ORIF of fractures around the knee
Continuous Passive Motion
at least 48 hours of continuous passive motion following ORIF of fractures around the knee
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Passive Motion
at least 48 hours of continuous passive motion following ORIF of fractures around the knee
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Independent ambulatory prior to injury
* No previous knee injury limiting motion
Exclusion Criteria
* Any contraindication to CPM (concomitant hip or ankle fracture)
* Open physis of tibia or distal femur
* Pathological Fracture
* Compartment Syndrome
* Neurovascular injury
* Fracture due to gunshot wound
* Greater than 21 days from fracture to definitive open reduction and internal fixation
* Fractures treated with definitive external fixation
* Open fractures
* Extensor mechanism injuries
* Likely problems in the judgment of the investigator with maintaining follow-up
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orthopaedic Trauma Association
OTHER
Prisma Health-Upstate
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyle J. Jeray, MD
Role: PRINCIPAL_INVESTIGATOR
Greenville Hospital System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greenville Hospital System Univeristy Medical Center
Greenville, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHS-12-06-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.